111 related articles for article (PubMed ID: 31250469)
1. Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis.
Rühlemann M; Liwinski T; Heinsen FA; Bang C; Zenouzi R; Kummen M; Thingholm L; Tempel M; Lieb W; Karlsen T; Lohse A; Hov J; Denk G; Lammert F; Krawczyk M; Schramm C; Franke A
Aliment Pharmacol Ther; 2019 Sep; 50(5):580-589. PubMed ID: 31250469
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the Gut Microbiota and Mycobiota in Italian Pediatric Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis.
Del Chierico F; Cardile S; Baldelli V; Alterio T; Reddel S; Bramuzzo M; Knafelz D; Lega S; Bracci F; Torre G; Maggiore G; Putignani L
Inflamm Bowel Dis; 2024 Apr; 30(4):529-537. PubMed ID: 37696680
[TBL] [Abstract][Full Text] [Related]
3. Investigating the metabolite signature of an altered oral microbiota as a discriminant factor for multiple sclerosis: a pilot study.
Boussamet L; Montassier E; Mathé C; Garcia A; Morille J; Shah S; Dugast E; Wiertlewski S; Gourdel M; Bang C; Stürner KH; Masson D; Nicot AB; Vince N; Laplaud DA; Feinstein DL; Berthelot L
Sci Rep; 2024 Apr; 14(1):7786. PubMed ID: 38565581
[TBL] [Abstract][Full Text] [Related]
4. Experimental infection with the hookworm, Necator americanus, is associated with stable gut microbial diversity in human volunteers with relapsing multiple sclerosis.
Jenkins TP; Pritchard DI; Tanasescu R; Telford G; Papaiakovou M; Scotti R; Cortés A; Constantinescu CS; Cantacessi C
BMC Biol; 2021 Apr; 19(1):74. PubMed ID: 33853585
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiome in primary sclerosing cholangitis: A review.
Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A
World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753
[TBL] [Abstract][Full Text] [Related]
6. Altered Gut Microbial Metabolism of Essential Nutrients in Primary Sclerosing Cholangitis.
Kummen M; Thingholm LB; Rühlemann MC; Holm K; Hansen SH; Moitinho-Silva L; Liwinski T; Zenouzi R; Storm-Larsen C; Midttun Ø; McCann A; Ueland PM; Høivik ML; Vesterhus M; Trøseid M; Laudes M; Lieb W; Karlsen TH; Bang C; Schramm C; Franke A; Hov JR
Gastroenterology; 2021 Apr; 160(5):1784-1798.e0. PubMed ID: 33387530
[TBL] [Abstract][Full Text] [Related]
7. A Pilot Integrative Analysis of Colonic Gene Expression, Gut Microbiota, and Immune Infiltration in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Association of Disease With Bile Acid Pathways.
Quraishi MN; Acharjee A; Beggs AD; Horniblow R; Tselepis C; Gkoutos G; Ghosh S; Rossiter AE; Loman N; van Schaik W; Withers D; Walters JRF; Hirschfield GM; Iqbal TH
J Crohns Colitis; 2020 Jul; 14(7):935-947. PubMed ID: 32016358
[TBL] [Abstract][Full Text] [Related]
8. Short-chain fatty acid and fecal microbiota profiles are linked to fibrosis in primary biliary cholangitis.
Lammert C; Shin A; Xu H; Hemmerich C; O'Connell TM; Chalasani N
FEMS Microbiol Lett; 2021 Apr; 368(6):. PubMed ID: 33836051
[TBL] [Abstract][Full Text] [Related]
9. Auto-aggressive CXCR6
Dudek M; Pfister D; Donakonda S; Filpe P; Schneider A; Laschinger M; Hartmann D; Hüser N; Meiser P; Bayerl F; Inverso D; Wigger J; Sebode M; Öllinger R; Rad R; Hegenbarth S; Anton M; Guillot A; Bowman A; Heide D; Müller F; Ramadori P; Leone V; Garcia-Caceres C; Gruber T; Seifert G; Kabat AM; Mallm JP; Reider S; Effenberger M; Roth S; Billeter AT; Müller-Stich B; Pearce EJ; Koch-Nolte F; Käser R; Tilg H; Thimme R; Boettler T; Tacke F; Dufour JF; Haller D; Murray PJ; Heeren R; Zehn D; Böttcher JP; Heikenwälder M; Knolle PA
Nature; 2021 Apr; 592(7854):444-449. PubMed ID: 33762736
[TBL] [Abstract][Full Text] [Related]
10. A disease-specific decline of the relative abundance of Bifidobacterium in patients with autoimmune hepatitis.
Liwinski T; Casar C; Ruehlemann MC; Bang C; Sebode M; Hohenester S; Denk G; Lieb W; Lohse AW; Franke A; Schramm C
Aliment Pharmacol Ther; 2020 Jun; 51(12):1417-1428. PubMed ID: 32383181
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune liver disease and the enteric microbiome.
Glassner K; Quigley EM; Franco L; Victor DW
AIMS Microbiol; 2018; 4(2):334-346. PubMed ID: 31294219
[TBL] [Abstract][Full Text] [Related]
12. Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework.
Shah A; Macdonald GA; Morrison M; Holtmann G
Am J Gastroenterol; 2020 Jun; 115(6):814-822. PubMed ID: 32250997
[TBL] [Abstract][Full Text] [Related]
13. The gut-liver axis in liver disease: Pathophysiological basis for therapy.
Albillos A; de Gottardi A; Rescigno M
J Hepatol; 2020 Mar; 72(3):558-577. PubMed ID: 31622696
[TBL] [Abstract][Full Text] [Related]
14. Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitis.
Furukawa M; Moriya K; Nakayama J; Inoue T; Momoda R; Kawaratani H; Namisaki T; Sato S; Douhara A; Kaji K; Kitade M; Shimozato N; Sawada Y; Saikawa S; Takaya H; Kitagawa K; Akahane T; Mitoro A; Yamao J; Tanaka Y; Yoshiji H
Hepatol Res; 2020 Jul; 50(7):840-852. PubMed ID: 32346970
[TBL] [Abstract][Full Text] [Related]
15. Protective and aggressive bacterial subsets and metabolites modify hepatobiliary inflammation and fibrosis in a murine model of PSC.
Awoniyi M; Wang J; Ngo B; Meadows V; Tam J; Viswanathan A; Lai Y; Montgomery S; Farmer M; Kummen M; Thingholm L; Schramm C; Bang C; Franke A; Lu K; Zhou H; Bajaj JS; Hylemon PB; Ting J; Popov YV; Hov JR; Francis HL; Sartor RB
Gut; 2023 Apr; 72(4):671-685. PubMed ID: 35705368
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota depletion exacerbates cholestatic liver injury via loss of FXR signalling.
Schneider KM; Candels LS; Hov JR; Myllys M; Hassan R; Schneider CV; Wahlström A; Mohs A; Zühlke S; Liao L; Elfers C; Kilic K; Henricsson M; Molinaro A; Hatting M; Zaza A; Drasdo D; Frissen M; Devlin AS; Gálvez EJC; Strowig T; Karlsen TH; Hengstler JG; Marschall HU; Ghallab A; Trautwein C
Nat Metab; 2021 Sep; 3(9):1228-1241. PubMed ID: 34552267
[TBL] [Abstract][Full Text] [Related]
17. The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer.
Sun L; Cai J; Gonzalez FJ
Nat Rev Gastroenterol Hepatol; 2021 May; 18(5):335-347. PubMed ID: 33568795
[TBL] [Abstract][Full Text] [Related]
18. Gut mycobiome of primary sclerosing cholangitis patients is characterised by an increase of
Rühlemann MC; Solovjeva MEL; Zenouzi R; Liwinski T; Kummen M; Lieb W; Hov JR; Schramm C; Franke A; Bang C
Gut; 2020 Oct; 69(10):1890-1892. PubMed ID: 31653787
[No Abstract] [Full Text] [Related]
19. Are Gender Differences Important for Autoimmune Liver Diseases?
Floreani A; Gabbia D; De Martin S
Life (Basel); 2024 Apr; 14(4):. PubMed ID: 38672770
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
